# Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung

> **NCT03589547** · PHASE2 · COMPLETED · sponsor: **Brown University** · enrollment: 11 (actual)

## Conditions studied

- Stage III Non-small-cell Lung Cancer

## Interventions

- **DRUG:** Durvalumab
- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT03589547
- **Lead sponsor:** Brown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-13
- **Primary completion:** 2024-01-31
- **Final completion:** 2026-02-18
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2026-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03589547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03589547, "Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03589547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*